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The partial sequence of a gene encoding the COOH terminus of a protein of apparent molecular 
weight of 160 kD associated with the flagellum of trypomastigotes of Trypanosoma cruzi (FL-160 
now renamed to FL-160-1) has been previously reported.  The COOH terminus of FL-160-1 
has an epitope, defined by 12 amino acids, which molecularly mimics a nervous tissue antigen 
of 48 kD found in myenteric plexus, sciatic nerve, and a subset of cells in the central nervous 
system. We now report that FL-160 is a family of highly related genes. The sequence has been 
determined for the entire open reading frame (ORF) of one of the members of the FL-160 gene 
family (FL-160-2) and three other partial ORFs. Sequence analysis reveals the various members 
of the FL-160 gene family to be ~o80% homologous in the predicted amino acid sequence, but 
all retain the 12-amino acid molecular mimicry epitope on the COOH terminus.  Comparison 
of the sequence of FL-160-2 to other sequences demonstrates amino acid homology to bacterial 
sialidase (27%),  members  of the  SA85 gene  family (25-30%)  and  the  shed  acute-phase 
antigen/neuraminidase/trans-sialidase  gene family (25-30%). Quantitative hybridization at high 
stringency suggests  750  copies of FL-160 are present  in the DNA of each parasite. Reverse 
transcription and sequence analysis demonstrates that at least five of the members of the FL-160 
gene family are transcribed.  The NH2  terminus of one of the FL-160 gene products was 
expressed and  antibodies  prepared.  Antibodies directed  to  either the COOH  or the NH2 
terminus of FL-160 bind a 160-kD T. cruzi protein. Both antibodies bind the surface membrane 
in the flageUar  pocket of the trypomastigote.  Antibodies to the NH2 terminus bind epineurium 
and scattered linear densities in sciatic nerve in a pattern distinct from the pattern with antibodies 
to the COOH terminus.  Thus, there are at least two distinct  molecular mimicry epitopes on 
the FL-160 molecule and both mimic epitopes found in nervous tissues. FL-160 may be involved 
in the generation of autoimmunity to nervous tissues by molecular mimicry, observed in chronic 
Chagas'  disease. 
T 
he World Health Organization estimates that 16-18 mil- 
lion people are infected with Trypanosoma cmzi, the pro- 
tozoan kinetoplastid  parasite that causes Chagas'  disease or 
American trypanosomiasis  (1). Most persons infected with 
T. cruzi  are asymptomatic.  10-30% of those infected with 
T. cruzi will have manifestations of Chagas'  disease in their 
lifetime (1). The manifestations include cardiomyopathy, neu- 
ropathies,  and dilatation  of colon or esophagus due to de- 
struction of the myenteric plexus (1). In sites of tissue de- 
struction, parasites are almost never found but inflammatory 
infiltrates oflymphocytes  and maerophages are frequent (2). 
Autoantibodies and lymphocytes  directed to cardiac and ner- 
vous tissue are frequently found in those with Chagas' dis- 
ease and experimental animal models of Chagas' disease (for 
a review see reference 3). This has led to the hypothesis that 
autoimmunity is  responsible  for  the  pathophysiology  of 
Chagas' disease. Many workers have demonstrated that au- 
toreactive Abs and lymphocytes are also directed to T. cruzi 
antigens  (for a review see reference 3).  Autoimmunity in 
Chagas' disease has been hypothesized to develop because of 
a loss of tolerance for self-antigens combined with molecular 
mimicry of host tissues (particularly  nervous  and cardiac 
tissues) by T. cruzi  (3). 
FL-160 is a candidate for molecular mimicry  of host nervous 
tissues by T. cruzi.  FL-160 has been defined by expression 
of the 3' fragment of a gene from T. cruzi,  representing the 
COOH terminus of the FL-160 protein (4-5). Abs to the 
COOH terminus FL-160 recombinant protein recognized 
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T. cruzi trypomastigotes, the motile form of T. cruzi found 
in mammals. These Abs directed to FL-160 also bound mam- 
malian myenteric plexus and peripheral nerve axons (4). The 
FL-160 cross-reactive epitope for binding of anti-FL-160 Abs 
to mammalian nervous tissues  was mapped to a single 12- 
amino acid peptide encoded within the 3' end of the FL-160 
gene (5). It was also shown that humans with Chagas' dis- 
ease make Abs to this cross-reactive  epitope and that these 
Abs bind human nervous tissue (5). Thus, the molecular mim- 
icry epitope of FL-160 may have a role in the development 
of autoimmunity in Chagas' disease. 
We now report that FL-160 is a family of genes in T. cruzi. 
We have cloned partial sequences of three members of this 
gene family and a  complete  sequence  of one.  All of the 
members cloned to date encode the 12-amino acid molecular 
mimicry epitope.  The NH2 terminus of FL-160 has amino 
acid homology to bacterial sialidases. Quantitative hybrid- 
ization suggests that 750 copies of the FL-160 genes are found 
in each parasite. At least five copies of the FL-160 genes ap- 
pear to be transcribed.  Abs directed to the COOH and NH2 
termini FL-160 both react with a 160-kD protein on the sur- 
face of T. cruzi trypomastigotes present on the surface mem- 
brane in the flagellar pocket of trypomastigotes. Abs to the 
NH2 terminus of FL-160 appear to cross-react with a differ- 
ent epitope of sciatic nerve than the Abs directed to the COOH 
terminus. Thus, FL-160 has two molecular mimicry epitopes 
in common with mammalian nervous tissues. 
Materials and Methods 
Parasites.  A subclone  of T. cruzi CL strain (6) was used for all the 
experiments described  in this paper. Trypomastigotes  were grown in 
coculture with murine BALB/c 3T3 fibroblasts in DMEM with 
10% newborn calf serum, and epimastigotes were grown in axenic 
cultures in liver-infusion/tryptone medium with 10% FCS (4). 
Cloning and Sequencing of FL,160 Genes.  The cloning and se- 
quencing of Fb160 was previously described (4, 5). FL160 will 
be renamed Fb160-1 to distinguish it from other members of the 
multigene family. FL-160-2 was selected from a library of genomic 
DNA cut with BamHI and ApaI, size selected for 3-8 kB frag- 
ments, and ligated into BamHI and ApaI cut Bluescript  TM SK- 
plasmid (pBS1; Stratagene, La Jolla, CA).  FL-160-3 and 4 were 
selected from a library of  randomly sheared T. cruzi DNA in X gt11 
that has been previously described (4). These clones were initially 
selected by hybridization with 32p-labeled Fb160-1 PCR products 
(see 3' FL-160 probes below) using high stringency washes (0.2 x 
SSPE [30 mM NaC1, 2 mM NaPO4, 0.2 mM Na2 EDTA, pH 
7.4]/0.1% SDS at 65~  Sequencing  was performed in both direc- 
tions along the open reading frame (OR.F)  1 using PCR.-mediated 
amplification  of •300-400  bp products (7). In brief, 1 ng of  cloned 
DNA was amplified for 27 cycles of 94 for 1 rain, 55 for 1 min, 
and 72 for 1 min. The reaction product was selected using a low 
melting point 2% agarose gel and purified from the agarose using 
glass absorption (Geneclean IITM; Bio 101, Inc., La Jolla, CA). 
Then,  one of the two primers in combination with the Dye 
Deoxy  TM Terminator Cycle Sequencing kit (Applied Biosystems, 
1 Abbreviations used in this paper: AS, antisense; CUB gene, calmodulin- 
ubiquitin-associated gene; GST, glutathione-S-transferase;  OR.F, open 
reading frame;  pBS, BhescriptTM;  S, sense; Tc exoant, T cruz/exoantigen. 
Inc., Foster City, CA) was thermocycled, the products purified on 
a spin column (CENTRI-SEP  TM,  Princeton Separations, Prince- 
ton, NJ), and run on an automated DNA sequencer (model 373; 
Applied Biosystems, Inc.) at the Molecular Pharmacology Phar- 
macology Facility, University of Washington. Where this did not 
lead to an unambiguous sequence, single stranded DNA (ssDNA) 
was used for template, ssDNA was generated from pBS FL-160 sub- 
clones using m13 helper phage and purified as recommended by 
the  manufacturer (Stratagene). Sequencing was carried out on 
ssDNA with either the fluorescence-labeled  forward (21M13) primer 
or T3 primer (Dye-primer kit  TM, Applied Biosystems, Inc.) or un- 
labeled primer and the Dye-terminator  TM kit, as necessary, to re- 
solve ambiguities. Oligonucleotides used for  sequencing were 
as follows (except as noted, number refers to first bases' relation 
to FL-160-2 for sense [S] or last bases' relation for antisense[AS]): 
sense oligos: S 1846 5'-GGGCTGTTTGTGTACGTG-3'; S 2812 
5'-ACAAGCACAACGCC'IGGG-3';  S 775 5'-CA_TGAGC~ATCC- 
ACCCAGCC-3'; S 479 5'-CCAGGATCCCGGACGGTGTTG-3'; 
Fb160-3 S 17 5'-GAAGGATCCAAATTGTTGGTACAGGCG-Y; 
S 1126 5'-GTCGGAT CAGCACTCTGCTGTAC-3';  and antisense 
oligos: AS 450 5'-CCGTGAATIEAGTCGTTGACG'fGCC-3';  AS 
1324 5'-CGTCCTTAAGCTTCCATGCAGCC-3';  AS 911 5'-GTG- 
TCGAATTCCTCATACCAC-Y; FL-160-4 AS 297 5'-CACGTC- 
GTTCATTTGCATCC-3'; AS  1381 5'-AGCCACTGAGCCAA- 
TTATTC-3'; AS 2195 5'-GGTGATGGTGTGGCGTC-Y;  AS 668 
5'-CGACCATCGTCCTCCATC-3'; AS-120 5'-ATGTGTGTGTG- 
GGCGGTG-3'; AS 178 5'-GGGGATCCTGAAACC~CTGTACC- 
AAC-3'; AS 219 5'-GGCCACAACGACACCATTC-Y; AS 180 
5'-GAGGATCCACGGAAAGAGTGAAACG-3';  AS 1757 5'-CTG- 
CCGTTGAGAATTCTCCTCCAC-Y; AS 1926 5'-CTGAATTC- 
CCTCGTAATCCTCATCTTC-Y and all primers used for PCR 
subcloning of FL-160-1 (5). Many primers have one to four base 
differences from the expected sequence to allow the addition of 
restriction endonuclease sites to the PCK products. Oligonucleo- 
tides were synthesized on a DNA synthesizer (model 381A; Ap- 
plied Biosystems, Inc.) at the Molecular Pharmacology Facility. 
Analysis  of DNA sequencing data was carried out using the In- 
telliGenetics  TM package of programs (IntelliGenetics Inc., Moun- 
tain View, CA). ORFs in GenBank and EMBL were translated 
in three frames and compared to the Fb160-2 amino acid sequence 
using a fast pairwise comparison of sequences (FastDB  TM program; 
IntelliGenetics Inc.). Alignments were made within this program, 
and homology refers to identical matches within the overlapping 
ORFs. 
PCR Amplification of FL.160 Transcripts.  Amplification of FL 
160 transcripts was accomplished  by reverse transcription with an- 
tisense oligo FL160-2 AS 450 for cDNA 1 and antisense oligo 
(Fb160-1 AS 488  (5)  5'-CTGAATTCAGTGGTTTTCCTCTG- 
CGG-3') for cDNA 2-5.5 #g of total trypomastigote RNA was 
reverse transcribed as previously described (8) except that a 37~ 
incubation temperature was substituted for 42~  and 2 #M of an- 
tisense primer was used. Balanced  PCK using 5% of the resultant 
cDNA, sense oligo related to the first 21 nucleotides of the T. cruzi 
spliced leader sequence (21-ME oligonucleotide sequence: 5'-CCC 
AAGCTTC~ATACAGTTTC-3')  and antisense  oligos: 
FL-160-2 AS 450 for cDNA 1, AS 1926 for cDNA 2, Fb160-2 AS 
1381 for cDNA 3, FL-160-4 AS 297 for cDNA 4, and FL160-2 
1324 for cDNA 5. PCK was carried out for 32 cycles  of 96~  for 
1 min, 54~  for 1 min, and 72~  for 2 min. Products were visual- 
ized by ethidium bromide staining of a 1% agarose  gel, transferred 
to  a  nylon  membrane (Hybond-NTM; Amersham,  Arlington 
Heights, IL), and probed with 3zP-labeled common oligonucleo- 
tide (FL-160-2 AS 911) and washed at high stringency. 
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point agarose  gel, cut with HindlII and EcoRI, ligatedqnto HindlII 
and EcoKI cut pBS (Stratagene), and a single clone sequenced  using 
the splice leader, Fb160-2 AS 450, and FL-160-2 AS 219 primers, 
and the Dye-terminator TM sequencing process as described above. 
FL-160 cDNA 3 and 4 PCR products were excised from a low 
melting point agarose gel, and directly sequenced with the 21-ME 
oligonucleotide and Fb160-2  AS 1381 for cDNA 3 or Fb-160-4 
AS 297 for cDNA 4 and the Dye-terminator TM sequencing pro- 
cess as described above. The FL-160 cDNA 3 and 4 PCR products 
were subcloned into the pCR plasmid vector (Invitrogen Corp., 
San Diego, CA). Plasmid was isolated from three colonies derived 
from cDNA 3 (FL-160  cDNA 3A-C) and two colonies  derived from 
cDNA 4 (FD160 4A and B). These plasmids used to prime a PCR 
reaction using oligonucleotides Fb160-2 AS 1381 for cDNA 3 or 
FL-160-4 AS 297 for cDNA 4 combined with FL-160-2  S 775. The 
resultant  PCR products were excised from a low melting point 
gel and  sequenced with oligonucleotides Fb160-2  AS 1381 for 
cDNA 3A-C or FL-160-4 AS 297 for cDNA 4A and B and the 
Dye-terminator TM sequencing process as described above. 
Production of FL-160 NH~-terminal Protein and A bs.  Production 
of the recombinant protein representing the NHz terminus of Fb 
160-3 was accomplished  using a PCR-generated product subdoned 
into pGEX-2 vector (9). The product was generated using primers 
F1r  $17 and FL-160-2 AS 1757, cut with BamHI and EcoRI, 
and ligated onto BamHI and EcoKI cut GST pGEX-2. This yielded 
a glutathione-S-transferase (GST) fusion protein with the Fb160- 
3 fused to GST (see Fig. 1). 
A clone of Escherichia coil XL-1BIue  TM (Stratagene) containing 
the appropriate PCR product cloned into pGEX 2 was grown to 
log phase, then stimulated with 0.1 mM isopropyl 3-D-thiogalac- 
topyranoside for 2 h. The fusion protein was found mainly in in- 
clusion bodies. The cell pellet was treated with 1 mg/ml lysozyme, 
washed with 0.1% deoxycholate, treated with 10 t~g/ml DNase 
1, washed with 1% NP-40, and the insoluble inclusion bodies solu- 
bilized in 8 M urea (10). This was dialyzed against PBS, and the 
resultant  soluble fraction analyzed by SDS-PAGE. Over 90% of 
the stained protein migrated at 83 kD, as expected for the fusion 
protein (data not shown). A New Zealand White rabbit was im- 
munized four times at monthly intervals with 250/~g of  the fusion 
protein, and the immune serum taken 1 wk after the last immuni- 
zation. Abs to GST were removed by absorption to GST coupled 
to Sepharose 4B (4), and Abs directed to the NH~ terminus of FL- 
160-3 affinity purified using the NH2-terminal fusion protein cou- 
pled to CNBr-activated Sepharose 4B (4). 
Southern and Northern Blots and Gene-counting Analysis.  Northern 
analysis was as previously described (4). Southern blots were per- 
formed  using  10/~g genomic  DNA of T. cruzi  CL strain  try- 
pomastigotes electrophoresed on a 1% agarose gel and transferred 
to nylon membranes (Amersham) after 20-min exposure to 0.25 M 
HC1, 30 min in 0.5 M NaOH, and 30 min in 0.5 M Tris buffer, 
pH 8.0, with 1.5 M NaCI for neutralization.  Gene-counting ex- 
periments were carried out comparing hybridization to 10-320 ng 
pFb160-3-PBS (7,000 bp) and T. cruzi DNA 61-1,000 ng bound 
to nylon membranes (Amersham) using a slot blot apparatus (PR 
600; Hoefer, San Francisco, CA) as described by the manufacturer. 
Hybridization at 42~  and high stringency wash at 65~  (0.2x 
SSPE/1%  SDS) were identical to those described previously for 
Northern blot analysis (4). Radioactivity bound was quantitated 
using phosphoimaging analysis (Phosphoimager SP; Molecular Dy- 
namics, Sunnyvale, CA) at the Markey Molecular Medicine Center 
(University of Washington).  32p-labeled 3' probes were prepared 
from PCR products of Fb160-1 previously described (5): probe 
3' 1: 48x Fb160-1 611-761 (see Fig. 2 [5]) and probe 3' 2:FL-160-1 
750-926 (see Fig. 2 [5]). The 5' probe prepared using a PCR product 
of Fb160-2 and oligonucleotides FI.,160-3 S 17 and FL-160-2 AS 
450. The location of  these probes with relation to the FL-160  genes 
is shown (see Fig. 3). The labeled product was synthesized using 
a 100-/A reaction containing 1 ng gel-purified PCR product, 5 #Ci 
ot-[32PldCTP (New England Nuclear, Inc., Boston, MA),  1/~M 
concentration  of each primer, 0.1 mM dNTP, 2 U TUB  TM en- 
zyme (Amersham), and buffer as supplied by the manufacturer 
(Amersham). Thermal cycle  incorporation of  label was by 27 cycles 
of 94~  for I min, 55~  for I min, and 72~  for I min. Labeled 
reaction product was recovered by precipitation in 2 M NH4Ac/ 
EtOH, and routinely >80% incorporation was obtained. Control 
probe for the gene count experiment was a 341-bp PCK product 
within the ORF from the calmodulin-ubiquitin-associated  gene 
(CUB gene) (11), provided by Dr. John Swindle (University ofTen- 
nessee, Memphis, TN). The probe was made using the oligonucle- 
otides  UB10 5'-GCAGGCACGTGGAACAGTGAAGG-3'  and 
UB13 5'-GCATTTTGTGGTTCACTTTG-3'.  This was hybridized 
to the pBS:2.65a' plasmid (5,500 bp, 12.5-200 pg) containing the 
CUB gene  on  the 2.65-kb  BgllI  fragment  of the calmodulin- 
ubiquitin locus from T. cruzi CL strain, as well as T. cruzi CL strain 
DNA as above. 
Immunofluorescence, Imrnunoperoxidase, Immunoelectron Microscopy, 
and Flow Cytometr 7 Analysis.  Live T. cruzi trypomastigotes were 
washed twice by centrifugation in DMEM, exposed to cold DMEM 
containing 5% goat serum and 10 #g/ml affinity-purified rabbit 
Abs at 4~  for 30 min, washed once by centrifugation,  and fixed 
in 4% paraformaldehyde in PBS for 30 min at 4~  Where compe- 
titions of Ab binding with recombinant proteins were performed, 
affinity-purified  rabbit Abs (10 #g/ml) were preincubated with 500 
#g/ml recombinant protein for 1 h at 4~  For immunofluores- 
cence and flow cytometry, the trypomastigotes  were exposed to 
1:300 diluted fluorescein-conjugated anti-rabbit  IgG (Tago Inc., 
Burlingame, CA) in DMEM containing  5% goat serum for 30 
min at 4~  Parasites were washed twice by centrifugation,  and 
evaluated using a fluorescence  microscope (Carl Zeiss, Inc., Thorn- 
wood, NY) or flow cytometry. Flow cytometric analysis was car- 
ried out using a FACScan  |  (Becton Dickinson & Co. Immuno- 
cytometry Systems, San Jose, CA) interfaced  with a computer (model 
310; Hewlett-Packard, Palo Alto,  CA).  An excitation source of 
488 nm was generated using a 15-roW air-cooled argon-ion laser. 
Fluorescence emission was collected through a 530/30 band pass 
filter. Autocomp software version 2.0 along with CaliBRITE beads 
(Becton Dickinson)  were  used to  set up  the instrument.  The 
Consort-30 program (Becton Dickinson) was used for acquisition 
and analysis of  data. For immunoelectron microscopy,  Ab-opsonized 
fixed trypomastigotes were exposed to biotinylated goat anti-rabbit 
Ab  and avidin-biotin-peroxidase complexes as described by the 
manufacturer  (Vector Laboratories, Inc., Burlingame, CA),  and 
processed as previously described (12). 
Immunoperoxidase  staining of  mouse sciatic nerve was performed 
using a nerve from a normal 10-wk-old C3H/He female mouse. 
7-/~m cryostat sections were cut and stained as previously described 
(5) using 10/~g/ml of affinity-purified  rabbit Abs to FL-160-3  NH2 
or FL-160-1  COOH terminus and biotinylated anti-rabbit IgG with 
avidin-biotin-peroxidase complexes (Vector Laboratories,  Inc.). 
Negative controls included anti-GST Abs (5) and rabbit anti-SA85 
1.1 affinity-purified Abs (13) (gift of Stuart Kahn, Department  of 
Pediatrics, University of Washington). 
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Figure  1.  Predicted  amino acid sequence of the NH2 terminus of FI_. 
160-3. The 5' terminus of the FD160-3 gene was expressed as a fusion 
protein with GST (see Materials and Methods). The predicted amino acid 
sequence of the expressed NH2 terminus of FL-160-3 is shown. 
Results 
FL-160 Is a Member of a Large Famil  r  of Hiehly Related 
Genes.  A  5-kb genomic fragment (1=L-160-2), bounded by 
BamHI and ApaI was found to contain the entire O1%1  = of 
a gene that is highly related  to the original gene fragment 
that defined the 1=L-160 gene (1=L-160 in references  4 and 5 
is now called 1=L-160-1). The sequence and the predicted O1%P 
of 1=L-160-2 are demonstrated  in Fig.  2.  The ATG that is 
hypothesized to encode the start methionine is underlined. 
The evidence that this is the start codon of the gene is that: 
(a) the codon has a Kozak start sequence consensus (14); (b) 
the one other in-frame ATG upstream (also underlined) does 
not have a Kozak start sequence consensus; (c) multiple stop 
codons are found upstream in all three reading frames;  and 
(aT) m1%NA sequence analysis demonstrates that the proposed 
start ATG is near the beginning of all five transcripts cloned 
and the first possible AT(; in a related transcript (see 1=L-160 
eDNA  1, below).  As in all  kinetoplast  genes described to 
date,  introns are not found in any of the genes for 1=L-160. 
The entire O1%F of the 1=L-160-2 gene has a predicted molec- 
ular mass of 109,126 dahons. Thus, posttranslation modifica- 
tion, such as glycosylation, likely affects the mobility of the 
mature trypomastigote 160-kD protein. In support of this, 
there are eleven possible N-linked glycosylation sites. The se- 
quence is serine and threonine rich,  and these two  amino 
acids comprise 18% of all amino acids. The sequence is acidic 
with a predicted pI of 4.2. Glutamic and aspartic acid residues 
are "~15%  of all  amino acids in the predicted  OR.1  =. 
Three related clones with partial O1%1=s have been isolated 
and  sequenced.  The  first  of these  is  the  original  FL-160 
genomic done (1=L-160-1) which contained 37% of the en- 
tire O1%F. The other two contain 95% (1=L-160-3) and 64% 
(PL-160-4) of the 3' end of the O1~. All four genes isolated 
to date are different with respect to both the nucleotide se- 
quence (range 5-11% differences)  and predicted amino acids 
(range  10-21%  differences;  see Figs.  2  and 3 A). 
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-31  GA~AGAGAG'PG  AGCAC'C  AG  AGGC  CC  GA~  CGTC  Gl,~,fl".r  l*Pr AC'IT  ~ 
178 &-GA---A  ..........  A-T----A  ................  G  ........  C-- 
I0  V  L  L  L  V  V  V  N  M  S  C  S  S  E  A  T  Y  G  K 
27  GG~I~  ~  CTC  Gq[~  GTCGq[~  ATCNk~DGTC  ~  #~  ~C AC'I~  AC  ~ 
232  TC .......  C---C--T----T  .......  G---  --G ......  G- - -TG-CCC -ACt"G- - - 
30  G  N  S  R  N  G  I  I  F  Q  G  g  E  S  F  S  D  S  M 
86 AG  GG~  RAGGAA~T  CATC  TI~C  ~  AG  A~T  CA~  GAI~IW~ 
313 C-AG  .......  G----AAA  ..............  T-A-T  ..................  TG- 
1  -  A-T-  -C  -  -  -AG  -  -  -  -GA-GA- 
49  N  A  T  L  V  Q  A  F  H  $  F  R  A  P  S  L  V  Y  V  N 
145 AATGCC  A~'I"z-*~GTAC  AGGC  GITITACTCITr  CC  Gq~CAC  CCTCTCPITdITF~ 
372 --C  -AAT  ..........  A  ........  T-CG  ...................  C---C--G-G 
23 --CAA&TrG  ............................................  C  ..... 
69  G  V  V  V  A  T  V  E  A  H  u  T  N  F  T  D  II  g  S  C 
106  ~GTGTCGTr  ~  CCPXTPGTIT~gAGCGCAT~AC  AC  ~C  GGATAAC  AAATCGT 
431 ......  T  ...........  C ...........  C--T  .......  C  .......  C-A  ....... 
82  ..................  C ......................  C .......  C-A ....... 
89  V  S  L  A  A  R  5  H  E  S  N  G  G  E  W  T  N  G  T 
261 GC  GTAA(~CTGC  AAGGTC  GATGC~IAAGCAA~T, GAGGC~AGTGGACARA~ 
690 .....  A-T  .......  C-  --G-  --~--T- -A  ......  ]%  ..................... 
141  -T  ................  A  .............  G .........................  C 
I08  A  I  V  F  D  H  Y  D  V  K  I  D  R  L  L  S  P  T  T  I 
322 GCCATCGT~CR~PTACGAC  G~AC CGCC~GAGC  CC~CTAC CAT 
569  ...........................................  T  ......  A--C  ..... 
200  ......................................................  G .... 
128  V  O  E  B  Y  R  E  T  N  A  L  v  G  G  Y  G  T  S  T  V 
181  ~GAI~GAAGAATACCGTGA~AA~"~GTCGGAGG~TA~T,  GCACGI~CAACGA 
608 --C-A---GTA-TAG~A---T---G  .............  G  ................... 
259 ..........  AGGG  -TA  ......................  G  ................... 
148  T  P  L  T  E  V  A  D  G  K  u  W  R  P  R  M  &  D  G 
640 CTCC~AC  GG  AGGTGG  CTGATGGTAAATAT~GGCC  CAGGATGGCGGACG  GriST 
667  -- 
319  .................  A- -  -G - - A- GG  .............................. 
167  V  P  H  G  T  O  D  E  E  K  X  B  F  X  W  N  Q  V  A  S 
498  TGTYCC GC  ATGGCACAGACGATGAGGAAAAGAAGGAGTTrAAGrr  C-GAACCAG~G~C 
376  ................................................  AAG-CGA--- 
187 T  S  R  V  P  Y  D  I  W  E  D  N  S  T  N  R  D  R  F  K  Q 
559 AC  G~GAGAGTTCC~ATGACA~DTG GGA~GATA~CC  AACC  GCGACC  G~CAJ~C 
434 .....  AG  ..............  T  ....................................... 
205  F  L  G  G  G  G  A  G  I  l(  N  B  D  D  G  R  Y  V  L  P 
620  AATr CCTGGGTGGTGGTGGC  GCAGG~  ATrAAGATC.-GAGGACGATC~TC  C-CI'AC~  C 
495  ....  T .........................  G .............................. 
228  I  Q  A  L  K  N  N  G  g  V  V  S  L  V  I  L  A  g  g  T 
681  TATTCAAGCCTTGAAARATAATGGAAAGGTCGTTTC GTTGGTCATC CTCGCCAAAAAA~CT 
556  .......................  & .....  C ............  T .....  A .....  -GGTTr- 
248 S  u  G  W  E  F  S  m  ,  G  T  S  H  E  G  C  I  Q  P  A  V  L 
742 ~IT A~  C~  GAG~Iq~ ARA~R~GTA  C  GAG  C  C  ATGAGG  GATG  CATC  CA  GC  C'~ GGTTC 
617 A  .......  T  ................  A  ....................  C  .............. 
269  E  W  I(  D  K  S  L  L  M  M  T  S  C  D  D  G  S  R  R  V 
803  ~1~aG  AAGGAT  AA~G~ ATGATG  AC  ~6s  6~ AGCC  GC  AG~T 
678  .............  A-  - -GAG--  -A  ..................................... 
289  Y  R  S  S  T  m  G  N  L  W  Y  E  E  Y  D  T  L  S  R  V 
864 TTAC  CGGTCAAGCACCATGG6GAA~PrGTGGTAT~AATACG  ACACTC~  AC  ~  ~TG 
739  ............................................................. 
309  W  G  N  S  L  K  R  T  G  H  G  V  Q  G  G  F  V  S  A  T  T 
925 T~GGGC  ~CTCG~CGCACA~C~  ACGGCGTGCAG~G~t~  GTCAGC  GC  ~CG A 
900  ............................................................. 
330  N  E  Q  K  V  I  L  V  S  R  P  V  Y  S  G  E  A  G  g  E 
986 CC  A~TGAACAGAAAGTCATC  CTCGTCAGTC  GGCCGGTATATTCC  GGGGAG~-C  GG~A 
861 T  .....  G  ............  T  .......................  T-A  -A-TCkT~J~A  ..... 
350  K  G  R  L  H  h  W  L  S  D  M  ~  R  Z  u  D  V  G  Q  1 
1067 RAAG~AC GAC~  AC~CTGTCGGACATG  CAGC  GA~ATGATGTTGGAC  AGATA 
922 --C---C  ...............  A--A  ..............................  T  .... 
1  .....  C--T .........  C .... 
370 S  A  E  M  ~  D  v  A  A  S  T  L  L  Y  A  T  V  E  V  P  S 
1108  T~ CGCTGAGAATGAGGAC  GTCG  C C GC  CAGCACTC'DG  crGs  GC  CACGGTCGAAGTGC  CGT 
983  ............................................................. 
24  ...............  A-T .....................................  C ..... 
391  L  E  G  G  E  K  K  R  E  K  K  L  Y  C  S  Y  E  V  A  A 
1169  C~T~GGAAGG~GAGAA~AAGGAAGAG~AI~ACTGC~gCGTAC  GA~  ~  C 
1044 .............................................  T  ............... 
85  ............  A----G  ....  A .......................  T .............. 
684  FL-160  Proteins Have Two Distinct Epitopes that Mimic Nervous Tissues FL- 160-2;~A 
FL-160-2 
FL-160-3 
FL-160-4 
FL-160-2~ 
FL- 160-2 
FL-160-3 
FL-160-4 
FL-160-2AA 
FL-160-2 
FL-160-3 
FL-160-4 
F1`- 160-2.1U~ 
FL-160-2 
FL-160-3 
FL-160-4 
FL-  160-2,1~ 
FL-160-2 
FL-160-3 
FL-160-4 
FL-160-2~ 
FL-160-2 
FL-160-3 
FX,- 160-4 
F1`- 160-2AA 
I'I,-160-2 
FL-160-3 
FL-160-4 
FL- 160-2AA 
FL- 160-2 
FL-160-3 
~1`-160-4 
F1`- 160-2~Ut, 
FL-16O-2 
FL-160-3 
F1`-160-4 
FL- 160-2AA 
FL-160-2 
F1`-168-3 
FL-160-4 
FL- 160-2J~ 
FL-160-2 
F'-,-160-3 
FL-160-4 
FL-160-1 
FL-160-2~ 
FL-160-2 
FL- 16fl-3 
FL-160-4 
FL-160-1 
FL-  160-2k~, 
1~-  160-2 
FL-160-3 
FL-160-4 
FL-160-1 
FL- 160- 2P.~ 
FL-160-2 
FL-160-3 
FL-160-4 
FL-160-1 
FL- 160-2AA 
FL-160-2 
F1`-160-3 
FL-160-4 
FL-160-1 
F~-160-2~ 
FL-160-2 
FL-160-3 
FL- 160-4 
1~-160-1 
FL- 160-2/~ 
FL-160-2 
FL-  160-3 
F1`- 160-4 
FL-160-1 
FL-160-2A~ 
1~,-160-2 
FL-160-3 
FL- 160-4 
F1`-160-I 
FL-160-2~% 
FL-160-2 
F1`-160-3 
FL-160-4 
BL-160-1 
411  A  B  D  G  X  Y  N  Z  A  F  V  D  L  T  E  X  L  B  8  H 
1230  ~;~.P~  ~  GGT~J~GTACJt  J~C  JL.~FG  ~G  GACCT~ ~C  GGAGA&G'/~G~  GGAC  AT  G 
1105  ............................................................. 
166  ....................................  Jr ....................... 
431  g  g  V  L  A  A  ~  N  ~  0  D  A  Y  Z  A  X  K  Y  R  C  G 
1291  .~t  ~~J~TG  JU~ JtGGJU~G C GTAC.~s  CJ~G~/~Gr ~C  C GCI"C~  G 
1166  .......................  G--CA  ........  C-A .........  G ............ 
207  --G  ....................  -G--G~ ........  C-A .........  G-A---G  ...... 
452  N  B  g  N  N  M  L  [4  D  C  G  E  A  L  T  1[  G  L 
1352  GG.'~.'~  *~ J~G  AAT~T]?GGCTC~G~GACTGTG  GTGA~:-,CCCI~  ~CG~AAGGGCT 
1227  ...........................  G .................  AT ........ 
2&[4  ...........  GI~vCI,  CA- - - ~- CAC  .........  J~G-  --GT  -A ......  T ........ 
470  V  G  F  1`  S  [4  K,..~.~S  T  G  X  T  ~  A  D  B  X  L  C  V 
1607  GG~ ~'s  C C ~C, JU~TC JUr~CT  C.~  ~  ~"GGG~ J~G  *~C  G~  (~'.I~C ~  GTG 
1262  ......  -C .......  G-G ...........  AC-GC--G  ........................ 
329  ............................  J~--GC--G  ........................ 
690  N  A  T  V  [4  G  ~  v  B  S  T  8  8  G  G  L  T  F  K  G  P 
1468  ~"W.-C~AC CG'I~CAC~GAJ~GT~TCCTG~TGGTGGATTGAC  GTTCAAAGGAC 
1343  .................................  'i'  ........................... 
390  ---A  ..................................  C ...................... 
511  G  A  W  A  g  W  P  V  G  o  14  R  O  T  V  0  Y  E  F  A 
1529  CCGGAGCGTGGGCGAAG'rGGCCTG'I"TGGCGACA-TC~GGCAGACTGI'GCCGTACCAC~ITI~C 
1404  ..................................  -G  ..........  A  .............. 
451  .......  AG  .....  G~  ...................  G ......  A  .................. 
531  N  S  X  F  T  L  V  A  P  V  S  I  D  X  A  ~  E  X  G  S 
1590  G~N~FP~G~I'FACTL'rI~GGC  C,C  CGGTGTCCATCG~AAGG  CTCCGGkG~0~N￿GCAGC 
1465  .........................  A ..............................  A .... 
512  ........  G ................  A ...........................  C ....... 
551  S  u  Z  P  L  H  G  V  R  14  N  D  A  Q  G  T  V  L  F  G  L 
1651  ~CCCCATCC~TGGGe~GTGP,  GG~TG,qACGATGC~C~O~GGCJkC~'~.'~'~x'~GGTC 
1526  ............................................................. 
573  ........  T .................................................... 
572  S  Y  T  H  D  [4  ~  W  R  I  I  L  N  G  S  L  L  T  L  P 
1712  TG'I'C  GTACACCC  AC  GJ~CAA~,GAG'Z'C~,AGCATAATCCI'C~ACGGCAGTCTITZ'GACG~  C 
1587  ...................................  T ......................  G-- 
634  ................  A---A  ..............  T ............  G .......  T-G-- 
592  A  [4  G  [4  D  A  G  W  E  A  N  K  X  u  H  V  V  L  '~  N 
1773  GGCGCATGGTGAGGATC-C  CGGATGGGAAGCARAC  AAGJUSATATCATGTGGTA~G 
1640  .............  A  ..............  C .......  .-G  ....................... 
695  ..........  A .....................  C ......................... 
612  D  Y  S  N  G  L  F  V  X  V  N  G  1(  g  l  Y  D  S  [4  F  O 
1834  GATTJ~r,F~aTAATGG  ~A  C GTG  AATG  GA  J~,  G/d~GATATAC  GACAGC  G  J*J~ 
1700  .......  A-G ..............................  G .........  -C ......... 
753  .......  A ......................  G .....  G---G  .....  G .....  C ..... 
1  .....  C- 
633  Y  [4  V  E  D  Y  E  D  Y  [4  S  g  ￿9  G  R  1`  Q  K  L  L 
1770  .............  A ........................  --C-~---A  ............... 
811  .........................  C---A ............  A  .......  A  .......... 
8  .........  ~I,  ..............  G~---A  ..................  C ............ 
653  S  5  [4  S  I  S  H  F  Y  l  G  G  D  G  K  [4  S  S  D  S 
1956  GAGC'I'CCCACAGCA'I'C~C  GC  J~-~'I"I~AC~.~GC~'GG GGACGG~AGCAGCI~GG~  ~C 
1031  .............................................  A  ............... 
672  -GAG  ..............................................  A  .....  G .... 
69  .................................  C .........................  A- 
673  Z  H  V  T  V  $  N  V  L  L  Y  N  R  L  L  X  8  [4  E  L  N 
2017  A~GTGACGGT~AGCAACGTC  CI~TACAAC  CGCI']?A~*I~GATGATGAGCTE  A 
1892  .....  A  .......................................  C-A  ............. 
933  G ..............................................  A'--A  ......... 
130  ............................................  -C-A  ............. 
694  P  P  H  g  T  N  A  A  A  A  A  B  A  E  V  P  A  P  B  G 
2098  AC  CCAC  ~AC  GJU~C  G~  GGCC  GCI~CTGC~GAGGC  GGAGGTC-C  CGGC  CC  CG  C-dEAGG 
1953  ................................  C ..............  T ............. 
984  ......  T--A  .....  G  .....  T .......... C .............. T ........  A  .... 
191  ......  T ............  G ............  C-G  ............  T ............. 
714  A  P  ]~  ](  S  8  L  S  Q  l)  S  E  X  D  T  T  L  S  P  Q 
2139  "I~CGCCrG~IAMO,  GTCATFTGAGTC.I,  ACC  CT~G&CACCAC~.--TATCAC  CAC/~, 
2016  ......  -C ....  C .....................................  C .......... 
1055  .......  C ....  C .............................  -G  ......  C .......... 
252  .......  C ....  C--A  ......  G-A---G-T  ...................  C .......... 
724  ][  Q  G  L  S  P  B  K  S  I(  [4  8  g  u  S  A  G  S  G  0  T 
2200  A&ACAAGGA~/~A'I~CGC~TC  AAAA/~ATGAA&AGI'A'PI~A~ CAGGTTCC  GGC~AGA 
2075  ......................................  -C ..................... 
1116  ....  -G-AC .....  A .............................................  (; 
313  --T  ...........  A  .............................................. 
755  T  S  ￿9  P  F  T  G  L  Y  T  S  A  A  E  G  E  V  E  [4  V 
2261  CAP.~I"rCTP.CTGATI'I'rACTGGCI'I~TACACCTC~GCCGCCGAGGGGG,~,GTC~I~C,  AAGT 
2136  ................  CG  ........................................... 
11-/'/  --C  .....  O .....  CCCG  ......  C--C  ...................  A ..........  T-- 
374  ........  G .......  C ............................................ 
775  A  A  S  S  A  G  S  A  S  S  L  T  P  T  P  G  [4  G  S  S 
2322  GGCJU}C  CAGCAGCGCTGGCTCGGC G~ATTGACTC  CAXCAC  CGGGAGAAGGCAGTI~CT 
2197  ...........................................  G ..............  C-- 
1230  ....  T- -G--  --T-T  ............  C ......  G ........  G ..............  C-- 
435  ....  T  .......  T-T  ...........  -C ......  G ........  G ..............  C-- 
FL-160-2~ 
FL-160-2 
FL-168-3 
FL-160-4 
FL-160-1 
FL-160-2/~ 
FL-160-2 
FL-160-3 
FL-160-4 
FL-160-1 
FL-160-2P~ 
FL-168-2 
rL-160-3 
FL-160-4 
FL-160-1 
F][,- 160-  2i~ 
FL-160-2 
F1`-168-3 
F1`-160-4 
F1`-160-1 
FL-160-2~A 
F1`-160-2 
F1`-160-3 
FL-180-4 
~L-160-1 
F1`-160-2A.~ 
FL-160-2 
FL-160-3 
FL-160-4 
FL-160-1 
F1`-I60-2AA 
FL-16O-2 
FL-160-3 
FL-160-4 
FL-160-1 
FL-1f0-2*Ir~ 
FL-160-2 
FL-160-3 
FL-160-4 
FL-160-1 
FL-160-2JU~ 
FL-160-2 
F1`-160-3 
FL-160-4 
FL-160-1 
FL-160-2JU~ 
FL-160-2 
FL-16O-3 
F1`-160-4 
FL-160-I 
FL-160-23u% 
FL-160-2 
FL-160-3 
FL-160-4 
F1`-160-1 
795  Q  l(  A  L  R  T  D  V  P  A  T  ]B  D  Q  F  R  8  B  0  V  [4 
2361  CAA~GCJ*Cr  l~d~CC  GJb.'l~.r  C C]~ C C ACI~  G~'I~C ~AA J~G'I~  JU~CAGGTGC 
2258  ............................................................. 
1208  .........................  T ..............  -C ................  A-- 
496  ..........  C ..............................  C ......  r .........  &-- 
616  S  $  L  [4  V  V  R  P  1(  T  ]~  0  T  0  E  A  V  V  A  T 
2464  /u  ~GC  CGATGAC~  J~AC GGAC  GAGGCGGTTGTC  GC  CAC 
2110  ................  A----~  ...............................  A ...... 
1360  ....  G ................  A ................  G-T--A----T  ............ 
557  ....  G ................  A ................  G-T--A ................. 
836  P  Q  R  [4  T  T  ~  0  R  P  O  H  S  T  L  S  D  A  S  E 
2505  TCCGCAGAGGA~ACC~CTGP,~GATCGG  CCGCAGCACAGCACTCTATCTG&TGCT~CAG 
2380  ............................................................. 
1421  ............................................................. 
&16  ............................................................. 
856  N  N  E  E  [4  S  S  H  [4  A  T  L  T  S  D  [4  O  N  F  G  P 
2566  ,~CkTGC40~RGTCGTCGTC  CC~'PI'CCGCChC  GCTCACCAGCG~CG.~GC  C 
2461  C  ............................................................ 
1482  G  ................  A ..................................  C-G---A-- 
679  G ...................................................  C-G---A-- 
077  E  G  R  ](  D  A  ~l  P  H  T  A  V  S  &  S  $  G  P  0  S 
2627  ~GGAC~,A/~GACGCACJETC  CC  CACACTC~  CGTGAGTG  CG,~GCAGC  GGCC  CC  GACTC 
2.502  ........................................  "-T  ..........  & ........ 
1563  -C--G-A  ..........  A- -~"  ............  G ....  G ...................... 
740  '-C--G-A  ..........  A--A  .................  G ..............  T ....... 
897  S  N  [4  T  I~  V  A  P  V  D  G  A  T  A  A  [4  E  P  S  T 
2688  ,~3"CC CJICAGC&CTG.q~GTGGCGCCCG'I~GC~.CG  GTGCCACAGCI'GCC  CATG~CC  C&GC~::T 
2563  ...................  CG  ..................................... 
1604  ...................  AGCG  ...................  C-G  ................ 
001  ......................  T .................. 
917  D  P  B  T  A  Q  G  H  D  E  V  L  D  G  O  O  A  A  P  G  N 
2749  G/~C~GG/O~CTGCTC  JU~,GGCCATGATG  JU~GTG'I'rG  GATGC~GkTGAT~  C GC&CC  ~  ~A 
2621  ..............................  T .............................. 
1665  ....................  G  ........................................ 
842  ......  C ...................................  G ..........  AA--A-T 
938  T  S  T  T  P  G  [4  T  K  X  IP  S  E  [4  N  A  T  $  [4  1` 
2810  AT~s 
2602  ............................................................. 
1726  ....................  C-A ....................................  C- 
902  - -'I"FGC  ................  A .........................  -,C"  .......  T--C 
958  D  H  O  L  L  L  E  [4  G  Q  F  D  L  8  A  [4  A  1`  Z 
2871  C~  JEC  C~T~ ~  L-  J.'l'l  "1'~  ~.~ C~CG  GG  C.A  G']~C  G,RCrT  G~  C C~C  C AT~ C.~-TC'TA2~'~ 
2763  ..........  G .................................................. 
1767  ---A  ......  G---G  .......................  "~--  --T-C  .............. 
063  ..........  A ...................  'FFT-AG--  -T--  -G--T  .............. 
977  G  D  S  T  V  H  G  C  V  5  R  V  F  G  L  L  L  L  G  L  W 
2929  GGT~C~C.ACCC.4I'C~P.CC~GTGTGTGt][~-~CGGGTG'I'FTGC-G~C'I'~TG~ 
2B01  ~  -'C  ......................................................... 
1845  .....  G  ................................  G'I'F .................... 
1026  .................  T ....................  GTT .................... 
990  G  T  A  A  L  F  ￿9  1003 
2090  GGGGCACC  GC  GGCT~.~'~TGAGGC~GG~GTGGJ~TGGTGTrTCTI~GTG  G~E 
2862  ..................  G ...........................  C-GC-T  ......... 
1906  --C  ...............  G  .....  A .....................  C-GC-TA  ........ 
1005  ...............  r--G.  ....  -C ......  A  .......  T- --T-C-GC-T--T  ...... 
FL-160-2  3051  CA~CAkCTGTC~AGCTCCC  P~CATCACTCP~/~CTGG~FCAGGGATACT'ITCTTF  3107 
F1`-160-3  2923  ..................  -C ..................  ~F  ..................  2960 
FL-160-4  1967  ....  ~ ......  G .......................  T .....  &--R-C---A-C---C-  2024 
~-180-1  1146  ..........  ~  ........  CT  ............  TTT---A ........  CT---  1203 
Figure  2.  DNA sequence of FL-160 genes  and cDNA an amino acid 
sequence  of FL160-2.  Nucleic acid sense strand sequences  (5' to 3') for 
genomic DNA clones of FL-160-2, FL-160-1, FL-160-3, and FL160-4,  and 
the FL-160 cDNA done 1 are shown aligned.  (Dashes) Sequence is iden- 
tical to Fb160-2. (Spaces) Gaps are placed to maintain the best homology. 
The nucleic acid sequence for partial FL-160 cDNA done 1 is a]so shown 
aligned to FI..160-2. The first 11 bases ofFI~160 cDNA clone 1 correspond 
to the 3' 11 bases of splice leader sequence for T. cruzi.  The ATG hypothe- 
sized to initiate  translation is underlined at base 1 of Fb160-2.  Another 
in-frame ATG, at base  -111,  is underlined.  The  -111 ATG is hypothe- 
sized not to initiate transcription because of the lack of Kozak consensus 
sequence for translation initiation, as well as the lack of ATG in the same 
spot in FL-160 eDNA I. The predicted amino acid sequence of FL-160-2 
is shown over the sequence. The 12-amino acid peptide previously mapped 
to be the epitope in Fb160-I, responsible for antigenic  mimicry (5) with 
mammalian nervous  tissue,  is underlined  with a double line.  Note that 
the sequences  are all identical  in this region  and that  the long ORF is 
the  same  for  aU  four  sequences  (data not  shown).  The  11  potential 
N-glycosylation sites are underlined with a heavy line. The nuchotide se- 
quence data has been submitted to EMBL/GenBank/DDBJ under the ac- 
cession  numbers  X70947,  X70948,  X70949,  and X70950. 
685  Van Voorhis  et al. A 
I  "  I 
5' Probe  Probes: 
met  FI-160-I 
I  homology 
,  ,I  beg;ns  1888 
Region 
encoding 
mimicry 
epllope  stop 
I  I  FHSO.~ 
9enomtc clone 
3' #1  3" It2  Region  ~  F1-160 genes 
used for hybridization 
Region  probes 
encoding 
mimicry  stop 
epltope  3010  FL-160-2 
2503  I  genomlc clone 
Amino  Nucleic 
Acid  Acid 
Homologlf  Homology 
with  wXh 
FL.160.2  FL.t60.2 
82%  90% 
100%  100% 
Region 
encoding 
mimicry 
epltope  stop 
I  I 
Region 
encoding 
mimicry 
epltope  stop 
I  I 
spliced 
lee~er  eDNA 
spltced  1 
lea~er  eDNA 
spliced  2 
lea(~er  cONA 
spliced  3 
lae(~er  cONA 
spliced  4 
lea~er  eDNA 
S 
FL-180-3  90%  95% 
genomlc clone 
FL-160-4 
genomle clone  112%  II1% 
Figure 3.  Alignments of FL-160 genes and cDNAs and related sequences. (A) Alignment  of the FL-160  genes and cDNAs. The region of the FL-160 
genes used for hybridization probes for Southern,  Northern, and slot blot hybridization are shown above FIr  The stop codon for the longest 
OKF and the region encoding the 12-amino acid molecular mimicry epitope is marked on each genomic clone. To the right of each genomic done 
is the percent that the clone is homologous  to the amino acid and nudeotide sequence of Fb160-2.  (Bottom) The alignment of cDNAs from Figs. 
2 and 5 shown schematically. (B) Alignment of the predicted amino acid sequence of Fb160-2 with the predicted amino acid of genes and pseudogenes 
listed in GenBank 72. Tc exoant and pseudogenes ffp85A and B are the most highly related, and may represent different members of the same gene 
and pseudogene family. The other genes are more related to FL-160-2  in their 5' end, and much of this relatedness is found within the homologous 
region to bacterial sialidases. The sialidase motif (SXDXGXTW), when complete, is shown as a black box within the sequence. Though these motifs 
are incomplete in FL-160-2, two to three amino acids of the sialidase motif can be found in regions aligned with the motifs in TCNA and the SA85 
genes. The location of the fibronectin III domain of TCNA and Fb160 is shown as an open box. 
Comparison of the FL-160-2 predicted amino acid sequence 
with the DNA  databases, translated into all three reading 
frames, using a pairwise comparison, demonstrated many se- 
quences that are significantly related. These are shown sche- 
matically in Fig. 3 B. The sequence most related was T cruzi 
exoantigen gene (Tc exoant) (Jazin, E. E., L. Aslund, D. O. 
Sanchez, J. Henriksson, U. Pettersson, and A. C. Frasch, un- 
published  data,  deposited  in  EMBL,  accession  number 
M88337)  which gave  a significance  of >139  SD  over  the 
mean. This sequence appears to be highly related at the amino 
acid (57% homology on alignment) and the nucleic acid level 
(64% homology on alignment). Two recently described pseu- 
dogenes are closely related to the FL-160 genes, and are likely 
to be members  of the FL-160 gene family (15).  These are 
48 and 40% homologous in the amino acid sequence in the 
longest ORFs (significance  12 and 29 SD over the mean). 
The four FL-160 genes, the T. cruzi exoantigen gene, and 
pseudogenes gp85A and B (FL-160 family)  are much more 
highly rdated to each other than the 85-kD surface protein 
(SA85) family (SA85 1.1 [I6], TSA 1 [17], and Tt34cl [18]) 
or the trans-sialidase (trans-sialidase [19]/neuraminidase [20]/ 
shed acute-phase antigen [SAPA] [21]) family (Fig. 3 B). Yet 
these two families are significantly related to the FL-160 genes 
(Fig. 3 B, significance >6 SD above the mean). The FL-160- 
2 predicted OILF contains a fibronectin type III domain (Fig. 
3 B), similar to that found in T. cmzi neuraminidase as first 
reported by Pereira et al. (20). This domain is defined by con- 
served aromatic and hydrophobic amino acids separated by 
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variable numbers of amino acids (20). The predicted amino 
acid  sequence of the FL-160-2  genes is highly related to a 
bacterial sialidase gene (22) (27% homology, significance >6 
SD above the mean). Note that the neuraminidase reported 
by Pereira et al. (20) also had 27% homology to the bacterial 
sialidases. Though the FL-160  genes do not contain com- 
plete sialidase motifs (SXDXGXTW),  two to three of the 
sialidase motif amino acids can be found at the sites where 
the bacterial  sialidases align to the FL-160-2  gene. 
Southern analysis of T. cruzi CL genomic DNA reveals that 
a large number of genes are related to the FL-160  family. 
Southern analysis demonstrates that the FL-160 related genes 
vary extensively  in restriction sites (Fig.  4 a).  We focused 
on three probes, one from the 5' end of the gene, and two 
from the 3' end of the gene (Fig. 2 diagrammatically shows 
locations of probes). One of the 3' probes includes the coding 
sequence for the peptide responsible for antigenic mimicry 
(3' probe 1). The other 3' probe is just 3' to this probe (3' 
probe 2). These probes are <50% homologous to SA85 genes 
and trans-sialidase genes, such that hybridizing and washing 
at high stringency should identify only members of the FL- 
160 family. The pattern on Southern hybridization for most 
restriction enzymes appears to be similarly complex whether 
a probe from the 5' end of the FL-160 genes is used or whether 
the probe is from the 3' end. The EcoRI digest shown in 
Fig. 4 a is an example of this. Most other enzymes tested 
gave a wide range of hybridization bands (e.g.,  AvaI, EagI, 
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EcoRV, HinclI, HindlII, NcoI, SaclI, ScaI, and XhoI, data 
not shown). Some restriction enzymes give less complex pat- 
terns.  For example, restriction of genomic DNA with PstI 
and hybridization with a probe from the 5' end of the gene 
Figure 4.  Southern and Northern hybridization data using probes from 
different regions of the FL-160-2 gene. Southern hybridization  was per- 
formed using digests of T cruzi CL strain genomic DNA and Pstl, EcoKl, 
and BamHI combined with ApaI enzymes. The blots were hybridized 
with labeled PCR fragments, one from the 5' end of the gene and two 
from the 3' end of the gene (3' probes I  and 2).  The 3' probe 1 encodes 
a region of the FL-160  genes shown previously to be responsible for anti- 
genic mimicry. More than 20 bands of different molecular weight could 
be seen for each digest and probe combination  except one. The PstI digest 
probed with the 5' probe gave a predominately 1-kb band. Northern blots 
were 10 #g of trypomastigote  total RNA hybridized with the same three 
probes. A single band of ,o4-5 kb was seen on all three autoradiograms. Figure  5.  Reverse  transcription  and  sequence  analysis 
demonstrates  transcription  of at least five members  of FIr 
160. (A) (Left) Ethidium bromide-stained  cDNA PCR prod- 
ucts run on a 1% agarose TBE gel. RNA from trylx>mastigotes 
was reverse transcribed  using a primer homologous to the 
3' end of the FL-160 genes. The cDNA was then amplified 
using PCR. The 5' sense primer in each case was identical 
to the first 21 bases of the spliced leader sequence. Since the 
spliced leader sequence is trans-spliced onto mRNA in a post- 
transcriptional  process, use of this primer should allow only 
amplification of mature mRNAs. The Y primers were:  Fb 
160-2 AS 1324 for cDNA 2, FL-160-2 AS 1381 for cDNA 
3, Fb160-4 AS 297 for cDNA 4, and FL160-2 AS 1926 for 
cDNA 5. Primer FL-160-4 AS 297 (PCR cDNA product 3) 
is homologous only to the FL-160-4 gene, whereas  primer 
Fb160-2 AS 1381 (PCR cDNA product 4) is not homolo- 
gous to FL-160-4, but is homologous to Fb160-2 and FL-160- 
3. This demonstrates that each oligonucleotide is able to prime 
a PCR product from mRNA, and two of these oligonucleo- 
tides are specific  for different mRNAs. (Right) The same prod- 
ucts  transferred  to a nylon  membrane  and hybridized  with 
a labeled oligonucleotide  (F1r  AS 911) homologous to 
the Fb160 genes within the region amplified. That binding 
occurs to each of the four PCR products  confirms that the 
PCR products  are all members  of the Fb160 family. That 
fragments  3 and 4 are the same size and hybridize to the FL- 
160 internal  probe is consistent  with the hypothesis  that at 
least two different FL-160 genes are transcribed into mRNA. 
(B) The partial sequence of three subdoues of FL-160 cDNA 
3 (A-C) and 2 subclones of FL-160 4 (A and B) are aligned 
with the sequence of FL-160-2 genomic done. (Uppercase  letters) 
Homologous bases with sequence above; and (/oucrcase  letters) 
nonhomologous. A consensus sequence is shown below each 
alignment. (Uppercase letters) Identical bases at that position 
for all six members.  None of the six sequences are identical 
and none of the cDNAs are completely  homologous to the 
Fb160-3  or FI~160-4 (data not shown).  More than 80% ho- 
mology between the various members  of the Fb160 family 
are observed and an ORF with more than 80% predicted 
amino acid identity with FL-160 is preserved in each cDNA. 
The nucleotide sequence data has been submitted  to EMBL/ 
GenBank/DDBJ  under  the  accession  numbers  X71867, 
X71868,  X71869,  X71870,  and X71871. 
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several PstI bands at 3-8 kb and a minor band at 1.8 kb is 
seen with 3' end probes. A wide band is found at 4-6 kb 
with BamHI (data not shown) and BamHI  +  ApaI diges- 
tion (Fig. 4 a), whether the probe is from the 3' or the 5' 
end of the molecule. This is probably due to conservation 
of sequence among the various members of the family. This 
sequence conservation  probably occurs  in  the noncoding 
regions because our full-length clone is bounded by BamHI 
and ApaI sites and none of our clones have a BamHI site 
in the coding sequence. The FL-160 genes do not seem to 
be arranged in tandemly repeating arrays of genes, as partial 
digestion with BamHI does not give hybridizing bands at 
4, 8, 12, 16 kb etc. (data not shown). Definitive proof that 
the genes are not arranged in tandem arrays awaits cloning 
large pieces  of  DNA encoding FL-160 genes and chromosomal 
localization. 
More than One Member of the FL-I60 Gene Family Is Tran- 
scribed.  Fig. 4 b shows a Northern blot of T. cruzi trypo- 
mastigote total RNA hybridized to several fragments of the 
FL-160 gene. Both the 5' (derived from FL-160.3 gene) and 
the 3' fragments (derived from the FL-160-1 gene) recognize 
an '~4-5 kb transcript.  None of the probes hybridized  to 
epimastigote  RNA (data not shown). 
T. cruzi and other kinetoplasts are unique in that they have 
a 39 base spliced leader sequence added by a trans-splicing 
mechanism in a posttranscriptional  process to the 5' end of 
the mature mRNA (23). This spliced leader can be used to 
obtain mature mRNA. The spliced leader sequence was used 
as a 5' sense primer in a PCR reaction using cDNA for tem- 
plate. First, cDNA was made using an antisense primer that 
is complementary  to all of the sequenced FL-160 genes near 
the 3' end of the coding sequence (FL-160.1 AS 488 [5]). 
This cDNA was then PCR amplified using the sense spliced 
leader  oligonucleotide  and  an  antisense  oligonucleotide 
predicted  from the FL-160 genes. 
A short cDNA transcript (FL-160 cDNA 1, 642 bp) was 
cloned and sequenced (Figs. 2 and 3 A). As expected, the 
first 11 bp of the 5' end were identical to the spliced leader 
sequence found on T. cruzi mKNA (23). Furthermore, the 
sequence was 79% homologous to the FL-160-2 genomic 
done. An AT(; exists at the identical position as the predicted 
start  of FL-160.2  (Fig. 2). 
Two antisense primers, each of which binds only a subset 
of FL-160 genes, were used to demonstrate that at least two 
subsets of genes are being transcribed. Fig. 5 A shows cDNA- 
driven PCR products that are made using antisense oligonu- 
cleotides homologous to the ORF of FL-160 genes combined 
with the sense oligonucleotide  homologous to the spliced 
leader sequence. These cDNAs are depicted schematically in 
Fig. 3 A.  Oligonucleotides were synthesized homologous 
to the region of  FL-160-2 bases 1362-1381 and FL-160-4 bases 
278-297  (Fig. 2). These regions had >60%  difference be- 
tween FL-160-2 and FL-160-4. Antisense oligonudeotide FL- 
160-2 AS 1381, which only binds cDNA homologous to FL- 
160-2, but not FL-160-4, was used to amplify cDNA 3. An- 
tisense oligonudeotide FL-160-4 AS 297, which only binds 
cDNA homologous to FL-160-4, but not FL-160-2 was used 
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to amplify cDNA 4. Note that the products are the same 
length, about 1,700 bp (Fig. 5), as predicted from the an- 
tisense primers binding the same region. 
To demonstrate that PCR products cDNA 3 and 4 were 
from the expected region of  FL-160 genes, PCR cDNA prod- 
ucts were made that were expected to be shorter (cDNA 2) 
or longer (cDNA 5) than PCR products cDNA 3 and 4. 
Antisense primers homologous to all of the FL-160 genes 
were used to generate cDNA PCR products 2 and 5: FL- 
160-2 AS 1324 for cDNA 2, and FL-160-2 AS 1926 for cDNA 
5. Products of the expected molecular weight are seen in Fig. 
5 A, and a diagram of the expected result is shown in Fig. 
3 A. The location of the spliced leader in the cDNA 1 corre- 
sponds to that of cDNAs 2-5, taking into account the ex- 
pected differences in length giving the homologous regions 
of the oligonucleotides used (shown diagrammatically in Fig. 
3 A). This supports the idea that in each case the sense spliced 
leader oligonudeotide and the antisense primers  gave the 
cDNA corresponding to the expected products. 
Fig.  3  shows  that  all PCR  products hybridize with  a 
common oligonudeotide expected to bind to all members 
of the FL-160 gene family (FL-160.2 AS 911). There was no 
apparent binding to irrelevant DNA such as pBS (data not 
shown). 
FL-160 cDNA PCR products 3 and 4 were directly se- 
quenced and found to represent multiple alleles, that is, in 
more than 10% of  positions, multiple nucleotides were found 
in sequence analysis. When sequencing from the 5' end, the 
first 11 bp were homologous to the spliced leader sequence, 
demonstrating that the PCR products were derived from re- 
verse transcription of mRNA and not contaminating genomic 
DNA. The FL-160 cDNA PCR products 3 and 4 were sub- 
cloned and five of these were sequenced as demonstrated in 
Fig. 5 B. Each of the five subdones is unique in sequence 
but has an ORF with about 80% homology to FL-160.2. 
Note that in comparison with the other sequences: an inser- 
tion of 6 bp occurs in FL-160 cDNA 4A; a deletion of 3 
bp occurs in FL-160 cDNAs 3A, 3B, and 4A; and a 24-bp 
region of only 22% homology to the other cDNAs occurs 
in FL-160 cDNA 3B. 
Taken together,  the results demonstrate that mRNA ho- 
mologous with unique regions from at least five FL-160 genes 
are synthesized. Thus, multiple genes appear to be transcribed. 
Quantitative Hybridization Suggests that 750 Copies of FL- 
160 Genes Are Present in the T  cruzi Genome.  Fig. 6 shows 
an autoradiogram  of hybridization  of the 5' and the two 3' 
probes to slot blots of T. cruzi genomic DNA and to FL-160- 
3 plasmid. These probes were chosen because they had <50% 
homology to T. cruzi sequences other than those in the FL- 
160 family. This blot was quantitatively scanned using phos- 
phoimaging analysis (Fig. 6). The dose-response of  both the 
FL-160-3 plasmid and the genomic T. cruzi DNA gave a linear 
increase in cpm with increased DNA except at the highest 
dose of DNA used. Since the number of plasmids and ge- 
nome equivalents of DNA applied to the filter was known, 
an estimate of the number of copies of the gene in the T 
cruzi genome was possible. The pBS-FL-160-3 plasmid  is 
"~7,000 bp, which means each nanogram of DNA represents Figure 6.  Quantitative hybridization to T. cruzi genomic DNA and FIr 
160-3 plasmid DNA suggests '~750 copies of FL-160 are present in the 
genome. An autoradiograph  of slot blot hybridization  of the FL-160 5' 
probe and the two 3' probes to duplicate quantities of T  cruzi genomic 
DNA (1,000-61  ng/slo O, human DNA (1,000 rig~slot), pBS (320 ng/slot), 
and pBS-Fb160-3 plasmid DNA (10-320 rig/slot). The radioactivity per 
sample was quantitated using phosphoimager analysis.  The values  for human 
DNA were subtracted from the T cruzi values and the values for pBS were 
subtracted from the pBS-pBS-Fb160-3  values. The mean of the two values 
is shown under each pair of slots. Using simple linear regression analysis 
of these values and the estimate that there is 160 fg of DNA/T cruzi cell, 
gives values of 752 genes/cell for the 5' probe, 720 genes/cell for the 3' 
probe 2, and 2,374 genes/ceU  for the 3  ~  probe 1. In experiments not shown, 
using an identical analysis for the CUB gene of 7?. cruzi,  2.4 genes/cell 
were observed. Work by Ajioka and Swindle (11) had shown that two 
copies of the CUB gene/cell are present, demonstrating the ability of the 
quantitative hybridization technique to estimate the number of genes within 
an 80% accuracy for the CUB gene. 
1.25  x  10  s plasmids.  Simple linear regression analysis was 
performed using the values for the plasmid hybridization and 
the plasmid equivalents applied. The R 2 of the linear regres- 
sion analysis for each of the probes was >0.99, demonstrating 
a linear relationship.  The values obtained by hybridization 
to T. cruzi DNA within the values in the linear range were 
then entered into the linear equation, and the number of genes 
present estimated. Each T. cruzi cell has  '~160 femtogram 
(fg) of DNA (24) which means that each microgram of DNA 
represents  6.3  x  106 genome equivalents.  The number of 
gene equivalents  determined by hybridization was divided 
by the genome equivalents of T. cruzi DNA. A mean of 752 
estimated copies per cell was found for the 5' probe (range 
732-768) and a mean of 730 was found for the 3' probe 2 
(range 718-742).  The 3' probe 1 gave a mean of 2,374 copies 
per cell (range 2076-2554), suggesting  that this probe identifies 
more members of the family or superfamilies relating to FL- 
160. Similar values were obtained when the experiment was 
repeated (data not shown). As a control, an identical analysis 
was performed using a probe and a reference plasmid con- 
taining the CUB gene, previously determined to have two 
copies per T cruzi genome (11). Again, a linear relationship 
was found with the quantity of  radioactivity bound with CUB 
probe hybridized to T. cruzi genomic DNA (0.5-1.5/~g) and 
to CUB reference plasmid (25-100 pg) (data not shown). A 
mean of 2.4 copies per cell was found for the CUB probe 
(range 2.04-2.58),  demonstrating that the quantitative hy- 
bridization technique gave a result within 80%  of the ex- 
pected number of genes for a two copy per cell gene. Taken 
together, these experiments suggest the FL-160 genes are part 
of a 750-copy  multigene family. 
Abs  to the COOH and the NH2  Termini of FL-160 Both 
Recognize a 160-ted Flagellar-pocket Surface Protein, but Each 
Binds a Different Cross-reactive Epitope of Mammalian Nervous 
Tissues.  Abs were prepared to the COOH terminus of the 
gene as previously published (4-5) and also to the NH2 ter- 
minus of the gene. The NH2-terminal recombinant protein 
was made by PCR. amplification of the 5' end of FL-160-3 
and splicing the product into pGEX-2 (9). The protein was 
expressed as a recombinant fusion protein with &histosoma 
japonicum GST. Rabbits were immunized and the Abs were 
affinity  purified. Fig.  7 demonstrates affinity-purified  Abs 
directed to either the COOH region (the FL-160-1 protein 
product) or the NH2 terminus recognized a 160-kD protein 
on Western blots of trypomastigotes. Both Abs recognized 
a protein distributed along the flageUum of the live trypo- 
mastigotes by immunofluorescence (Fig. 8,  b and c) or im- 
munoelectron microscopy (Fig. 8, e andJ). If trypanosomes 
were fixed and treated with 0.1% Tween detergent before 
staining,  more diffuse  cytoplasmic staining was  noted in 
trypomastigotes and amastigotes (data not shown). This sug- 
gests that anti-FL-160 Abs react with trypomastigote  flagellar 
membranes, but that the antigen is more evenly distributed 
in  permeabilized  trypomastigotes and  amastigotes.  Flow 
cytometry analysis demonstrated that anti-FL-160  Abs bind 
live trypomastigotes (Fig. 9). A monomorphic  curve of fluores- 
cence was observed, suggesting that all trypomastigotes  bind 
both anti-NH2  and anti-COOH-terminal  FL-160  Abs on 
their surface. The Ab binding demonstrated by flow cytom- 
etry was abrogated by excess recombinant fusion protein but 
not GST recombinant protein, showing antigen specificity. 
Figure 7.  Western blots demonstrate  antibodies to the 5' end and 3' 
end of FD160 bind to a 160-kD protein of mammalian forms of T cruzi. 
An autoradiograph  of a Western blot. Each lane has 5  x  106 parasite 
equivalents of lysates, run on a 10% SDS-PAGE gel, and transferred to 
nitrocellulose. (T) Lanes have trypomastigote  lysates; (E) lanes have epi- 
mastigote lysates. Lanes were reacted with 20/~g/ml of affinity-purified 
anti-FL-160 Ab  (directed either  to  the NH2  or COOH  terminus)  or 
nonimmune rabbit IgG, and then lzSI-protein A. Autoradiography  was 
for 18 h for the anti-Fb160 COOH-terminal lanes or 120 h for the anti- 
Fb160 NH2 terminal and rabbit IgG control lanes. 
690  Fb160 Proteins Have Two Distinct Epitopes that Mimic Nervous  Tissues Figure  8.  Immunofluorescence  and  immunoelectron  microscopy  demonstrate  anti-Fb160  antibody binding  limited  to  the  flagellar pocket  of 
trypomastigotes.  (a-c) Immunofluorescent-labded  trypomastigotes;  (d-J) immunoperoxidase-labded  trypomastigotes  viewed by transmission electron 
microscopy. (a and d) Controls without Ab; (b and e) reacted with anti-NH2-terminal  FL-160  Ab; (c and  j) reacted with anti-COOH-terminal FL-160 
Ab. In experiments not shown, neither nonimmune rabbit IgG nor anti-GST rabbit IgG reacted with the parasites. (a-c) x 670; (d)  x 11,200; (e) x 27,600; 
and (f)  x16,700. 
Anti-FL-160  Anti-FL-16g 
Amino Terminus  Carboxy Terminus 
i  i  I  , 
Log  Fluorescence Intensity  Log  Fluorescence  Intensity 
Figure  9.  Flow cytometry demonstrates staining of live parasites by Abs 
to the NH2 and COOH termini  of FL-160. Two tracings of relative cell 
number (linear scale) and fluorescence intensity (log scale) are shown after 
indirect immunofluorescence was performed on live trypomastigotes. (Left) 
Tracing shows trypomastigotes reacted with: only fluoresceine-conjugated 
anti-rabbit Ab (FCARA) (  ); anti-NH2  terminal  FL-160 Ab and 
then FCARA (  .....  ); anti~  terminal  FL-160 Ab plus 250 #g/ml 
FL-160-3 NH2-terminal GST fusion protdn and then FCARA (----); anti- 
Frozen sections  of murine sciatic nerve were exposed to 
a~inity-purified anti-FL-160 Abs and binding demonstrated 
by immunoperoxidase. Abs to the NH2 terminus of FL-160 
react with epineurium and occasional linear densities within 
the nerve (Fig. 10). In contrast, anti-FL-160 COOH-terminal 
Abs do not bind to epineurium, but rather bind a much higher 
number of linear elements within peripheral nerve,  which 
probably correspond to peripheral nerve axons (Fig. 10). Thus, 
the epitopes the anti-FL-160 NHz and COOH-terminal Abs 
recognize are distinct. This experiment has been repeated four 
NH2-terminal  Fb160  Ab  plus  GST  and  then  FCARA  (-..-).  (Right) 
tracing shows trypomastigotes reacted with: only FCARA (  ); anti- 
COOH-terminal  FI.-160 Ab and then  FCARA (  .....  );  anti-NHz- 
terminal Pb160 Ab plus 250/Lg/ml FL-160-1  COOH-terminal-GST trans- 
ferase fusion protein  and then FCARA (-'-'); anti-NHz-terminal  FL-160 
Ab plus 250/zg/ml GST and then FCARA (....). 
691  Van Voorhis et al. Figure  10.  Abs directed  to the NHz terminus  of FL-160 bind to distinct  structures  of sciatic nerve compared  with Abs directed  to the COOH 
terminus of FL-160. Immunoperoxidase-stained  sciatic nerve frozen sections counterstained  with methyl green are shown.  (Center) Exposed to af~nity- 
purified anti-COOH-terminal Fb160 Abs, and developed with biotinylated  anti-rabbit Ab, avidin-peroxidase, and diaminobenzidine.  Note the multiph 
streaks  throughout  the longitudinal section  of the nerve in the same pattern  as axons.  (Right)  Exposed  first to anti-NHz-terminal FL-160 Abs and 
developed in the same way. Note the strong reaction with the epineurium and the scattered linear staining within the nerve. The control (left) is mouse 
nerve that was not exposed to rabbit Abs, but was otherwise treated the same as the other sections. Note that little staining is seen. A pattern  identical 
to this was seen if the Abs were reacted with an excess of their immunizing recombinant  protein,  or if anti-SA85  1.1 is used.  x232. 
times,  and an identical result  obtained  each time, i.e., the 
staining  of sciatic nerve is different with the anti-FL-160 
COOH and NHz-terminal Abs. Abs to the SA85 1.1 sur- 
face protein (13, 16), provided by Stuart Kahn, did not bind 
murine sciatic nerve (data not shown). 
In experiments not shown, recombinant fusion protein of 
the FL-160 NH2 terminus-GST eliminates the staining  of 
murine sciatic nerve with anti-NH2-terminal  FL-160 Abs. 
Recombinant FL-160 COOH terminus-GST or GST pro- 
tein do not inhibit the nerve staining of anti-NH2-terminal 
FL-160 Abs. Thus the binding of anti-NH2-terminal FL-160 
Abs to nerve can be competed only by recombinant proteins 
containing the NH2 terminus of FL-160. 
Discussion 
These findings suggest that FL-160, the flagellum-associated 
160-kD protein of T cruzi trypomastigotes, is expressed from 
a family of about  750  genes  and or pseudogenes.  PCR- 
mediated cDNA synthesis with two oligonucleotides specific 
for different genes shows that at least five copies of the genes 
are transcribed. Abs, directed to two different regions of the 
FL-160 protein, bind to a 160-kD protein on the outer sur- 
face of the cell membrane in the flagellar pocket of trypo- 
mastigotes. Finally, both the NH2 and COOH terminus of 
FL-160 protein have distinct molecular mimicry  epitopes that 
are homologous to mammalian nervous tissues. 
The predicted amino acid sequence of  FL-160-2 has recog- 
nizable domains. The NH2 terminus has a putative signal se- 
quence (25) followed by a region with 27% homology to 
bacterial  sialidase. The next region is homologous to the 
fibronectin type III domain. The COOH terminus lacks the 
amino acid repeats noted in many other surface antigens of 
T. cruzi but has the 12-amino acid molecular mimicry epi- 
tope. Finally, the COOH terminus has a putative signal for 
addition of a glycosyl-phosphotidylinositol  anchor (26, 27). 
The genes of the FL-160 family are highly related to one 
another (>80% homology of amino acid sequence among 
sequenced genes and mRNAs reported here). The FL-160 
genes are also highly related to several  T. cruzi genes deposited 
in the DNA databases. The similarity of the Tc exoant (un- 
published sequence  in EMBL, see above) sequence  to FL-160-2 
(Fig. 3; 57%  homology of the amino acid sequence) sug- 
gests it is a member of the same family as FL-160 and align- 
ment to FL-160-2 suggests Tc exoant is missing 47 amino 
acids from the COOH terminus. Pseudogenes gp85B (c1821) 
(15) and gp85A (ORF 1) (15) are also highly related to FL- 
160-2 (Fig. 3, 40 and 48% homology of the amino acid se- 
quences, respectively). The FL-160 genes reported here are 
cloned from a different strain than Tc exoant, gp85A, or gp85B 
and some of the differences in sequence could be attributed 
to differences  between different strains of  parasites. The gp85A 
and gp85B sequences are designated pseudogenes because no 
initiation codon could be identified  and no homologous 
mRNA could be identified (15). Abs directed to the trans- 
lated product of the OILF 1 of gp85A bound a 160-kD pro- 
tein (15), consistent  with these pseudogenes being part of 
the same family as FL-160 genes. Thus, it is possible that 
some of the 750 copies of the FL-160 family, identified by 
quantitative  hybridization studies, are pseudogenes. 
692  FL-160  Proteins  Have Two Distinct Epitopes  that Mimic Nervous Tissues FL-160 is also related to bacterial sialidases and to T. cruzi 
85-kD surface  protein (SA85) and SAPA/neuraminidase/trans- 
sialidase genes. The SA85 and trans-sialidase  families have also 
been shown to be related to bacterial sialidase genes (15-22). 
The homology  between the FL-160, SA85, and trans-sialidase 
families are highest in the region of homology to bacterial 
sialidases. For this reason, we propose that the group of FL- 
160, SA85, and trans-sialidase  genes are a superfamily of  genes 
related to bacterial sialidases as proposed by Campatella et 
al.  (28) for the latter two families. 
Abs to the NH2 or the COOH terminus of the FL-160 
protein localize the protein on the surface of the cellular mem- 
brane of the flagellar pocket.  Western blots with both Abs 
demonstrate binding to a 160-kD protein of trypomastigotes. 
Flow cytometry demonstrates that both Abs bind all of the 
parasites in the population and that this binding is competed 
away by recombinant FL-160 protein. Ab binding to live para- 
sites demonstrates that the Abs bind to the surface membrane 
in the flagellar pocket by fluorescence microscopy and trltra- 
structural localization. These Abs are directed to the recom- 
binant proteins derived from two different FL-160 genes that 
are "~80% related. These experiments, taken together, dem- 
onstrate that the Abs bind to proteins of identical molecular 
weight and localization.  The role of the FL-160 protein in 
the physiology of the trypomastigote and the flagellar ap- 
paratus  is unknown at present.  One possibility is that the 
region with sialidase homology is employed for carbohydrate 
binding and/or cleavage. 
Like Tr'ylmnosoraa brucei, T. cruzi has large numbers of genes 
for its mammalian stage surface proteins. T. brucei generally 
expresses only one member of this gene family at a dm~ Unlike 
T  brucei, T  cruzi mammalian forms express many members 
of its  surface proteins  at once. The 85-kD surface protein 
(SA85) family has been shown to be a large gene family of 
which at least nine members are transcribed and three are 
translated  simultaneously  (13). At least five of the FL-160 
genes appear to be transcribed. By extrapolation to the results 
with the SA85 family, we hypothesize that many of the FL- 
160 gene family are transcribed and translated. If this is true, 
it would imply that the 160-kD protein that is localized to 
the outer membrane of the flagellar pocket is actually made 
up of a number of related proteins.  These proteins  would 
have 10-20% amino acid differences, yet it is interesting that 
they are retain the molecular mimicry epitope for mammalian 
nervous tissues found within the COOH terminus of the 
FL-160 proteins. Whether this sequence  is conserved  by chance, 
for a functional purpose, or for immune evasion via molec- 
ular mimicry is unknown. 
There are many possible reasons for the apparent diversity 
of expression of SA85 and FL-160 surface proteins. One pos- 
sibility is that the diversity in surface proteins somehow leads 
to immune evasion. The various peptides generated by the 
variations in sequence, bound in MHC molecules, may be 
responsible for the polyclonal  lymphocyte proliferative  response 
observed in acute Chagas' disease  (8, 29). The polyclonal lym- 
phocyte proliferative response may be responsible for the 
general suppression in lymphocyte responses after this prolifer- 
ative response, and the general suppression in lymphocyte 
responses may be responsible for the persistence of the infec- 
tion in the mammalian host. The variations in sequence may 
also direct the immune response away from functional do- 
mains, such as domains responsible for trans-sialidase func- 
tion. Another possibility is that the SA85 and FL-160 sur- 
face  proteins are involved  with host eel1  binding or interaction. 
Diverse binding proteins may be required to bind the wide 
variety of calls and mammalian hosts  that T. cruzi infects. 
Both the NH2 and the COOH termini of FL-160 appear 
to have different molecular mimicry  epitopes for mammalian 
tissues. This is evidenced by the distinct pattern of binding 
of sciatic nerve by Abs directed to the NH2 and COOH ter- 
mini of FL-160. Furthermore, binding by anti-FL-160 NH2- 
terminal Abs could be blocked by recombinant protein bearing 
the  NHz  terminus of FL-160, and  not  the recombinant 
COOH terminus of FL-160. This suggests that there are two 
distinct molecular mimicry  epitopes for mammalian nervous 
tissue on FL-160. In contrast, affinity-purified Abs to T. cruzi 
surface antigen recombinant SA85 1.1 protein did not react 
with mammalian nervous tissue. This suggests that the mo- 
lecular mimicry  of  mammalian nervous tissues by FL-160 may 
be unique, and not a general property of T. cruzi surface an- 
tigens. It is possible that the cross-reactive immune response 
to FL-160 has a role in the pathophysiology  of the damage 
to nervous tissue observed in chronic Chagas'  disease. 
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